Faculty Collaboration Database

Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies. Clin Lymphoma Myeloma Leuk 22(7): p. e495-e497

Date

02/14/2025

Author List

Mohan, M., S. Nagavally, N.N. Shah, L. Michaelis, S. Chhabra, A.D. Souza, S. Abedin, L. Runaas, G.S. Guru Murthy, W. Longo, M. Hamadani, B. Dhakal, P. Hari, and T.S. Fenske

Author

Walter L. Longo MD Professor in the Medicine department at Medical College of Wisconsin

© 2026 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 2UL1TR001436) at the National Institutes of Health (NIH).

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty

Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies. Clin Lymphoma Myeloma Leuk 22(7): p. e495-e497

Date

Author List

Author